Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan 24;2007(1):CD005164.
doi: 10.1002/14651858.CD005164.pub2.

Elective surgery for benign liver tumours

A Colli  1 , M Fraquelli, S Massironi, A Colucci, S Paggi, D Conte
Affiliations

Elective surgery for benign liver tumours

A Colli et al. Cochrane Database Syst Rev. .

Abstract

Background: Benign liver tumours (haemangioma, focal nodular hyperplasia, and hepatic adenoma) have different prevalence and prognosis. Spontaneous rupture and malignant transformation can complicate hepatic adenoma. Elective surgery is controversial, and indications are represented by uncertain diagnosis, presence of symptoms, and prevention of major complications.

Objectives: To assess the beneficial and harmful effects of elective surgery of benign liver tumours. We identified 31 cases series. These were small (with less than 60 participants) and the types of tumours mixed. These studies reported no significant mortality, but in the six studies with mortality it ranged from 1% to 17%.

Search strategy: The Cochrane Hepato-Biliary Group Controlled Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (searches in Issue 1, 2006), MEDLINE, EMBASE, CancerLit, and Science Citation Index Expanded (SCI-EXPANDED) (searched December 2005). A further search included the proceedings of major hepatological and surgical congresses (Annual Meetings of the American Association for the Study of the Liver (AASLD) and European Association for the Study of the Liver (EASL)), and examination of the references of relevant papers and reference lists of the identified studies.

Selection criteria: Randomised clinical trials in adult patients with benign liver tumours without indications for emergency surgery in which elective surgery (resection) versus no intervention or sham operation are compared.

Data collection and analysis: All trials identified through searches were evaluated for eligibility for inclusion. We intended to extract relevant data in order to analyse the outcomes as per our published protocol using intention-to-treat analysis.

Main results: We could not identify any randomised clinical trials.

Authors' conclusions: We were unable to find evidence supporting or refuting elective surgery for patients with benign liver tumours. We need large, long-term randomised clinical trials with adequate methodology to assess the benefits and harms of elective surgery.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

  • doi: 10.1002/14651858.CD005164

References

References to studies excluded from this review

Arnoletti 1999 {published data only}
    1. Arnoletti JP, Brodsky J. Surgical treatment of benign hepatic mass lesions. American Surgeon 1999;65:431‐3. - PubMed
Belghiti 1993 {published data only}
    1. Belghiti J, Paterson D, Panis Y, Vilgran V, Flejou JF, Benhamou JP, et al. Resection of presumed benign liver tumors. British Journal of Surgery 1993;80:380‐3. - PubMed
Belli 1992 {published data only}
    1. Belli L, Carlis L, Beati C, Rondinara G, Sanalone V, Brambilla G. Surgical treatment of symptomatic giant hemangiomas of the liver. Surgery, Gynecology & Obstetric 1992;174:474‐8. - PubMed
Brouwers 1997 {published data only}
    1. Brouwers MA, Peeters PM, Jong KP, Haagsma EB, Klompmaker IJ, Bijleveld CMA, et al. Surgical treatment of giant hemangioma of the liver. British Journal of Surgery 1997;84:314‐6. - PubMed
Catalano 1977 {published data only}
    1. Catalano PW, Early ME, Topolosky HW, Martin EW, Carey LC. Focal nodular hyperplasia of the liver: report of of six patients. Concepts of surgical management. Cancer 1977;39:587‐91. - PubMed
Charny 2001 {published data only}
    1. Charny CK, Jarnagin WR, Schwartz LH, Fommeyer HS, Matteo RP, Fong Y, et al. Management of 155 patients with benign liver tumours. British Journal of Surgery 2001;88:808‐13. - PubMed
Cherqui 1995 {published data only}
    1. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, Meignan M, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological and pathological correlations. Hepatology 1995;22:1674‐81. - PubMed
Closset 2000 {published data only}
    1. Closset J, Veys I, Peny MO, Braude P, Gansbeke D, Lambilliotte JP, et al. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. Hepato‐gastroenterology 2000;47:1382‐4. - PubMed
Descottes 2003 {published data only}
    1. Descottes B, Glineur D, Lachachi F, Valleix D, Paineau J, Hamy A, et al. Laparoscopic liver resection of benign liver tumors. Surgical Endoscopy 2003;17:23‐30. - PubMed
Egea 1996 {published data only}
    1. Egea AM, Pozo Rodrigriguez M, Vicente Cantero M, Abellan Atenza J. Indication for surgery in the treatment of hepatic hemangioma. Hepato‐gastroenterology 1996;43:422‐6. - PubMed
Farges 1995 {published data only}
    1. Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection?. World Journal of Surgery 1995;19:19‐24. - PubMed
Gugenheim 1986 {published data only}
    1. Gugenheim J, Mazza D, Baldini E, Evangelista A, Iovine L, Mouiel J. Surgical treatment of benign hepatic tumors. A safe and efficient choice. Minerva Chirurgica 1995;50:161‐5. - PubMed
Herman 2000 {published data only}
    1. Herman P, Pugliese V, Machado MA, Montagnini AL, Salem MZ, Bacchella T, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World Journal of Surgery 2000;24:372‐6. - PubMed
Iwatsuki 1988 {published data only}
    1. Iwatsuki S, Starlz TE. Personal experience with 411 hepatic resections. Annals of Surgery 1988;208:421‐34. - PMC - PubMed
Kerlin 1983 {published data only}
    1. Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PF. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 1983;84:994‐1002. - PubMed
Kim 2004 {published data only}
    1. Kim J, Ahmad SA, Lowy AM, Buell JF, Pennington LJ, Moulton JS, et al. An algorithm for the accurate identification of benign liver lesions. An algorithm for the accurate identification of benign liver lesions. American Journal of Surgery 2004;187:274‐9. - PubMed
Leconte 2000 {published data only}
    1. Leconte I, Beers BE, Lacrosse M, Sempoux C, Jamart J, Materne R, et al. Focal nodular hyperplasia: natural course observed with CT and MRI. Journal of Computer Assisted Tomography 2000;24:61‐6. - PubMed
Leese 1988 {published data only}
    1. Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12‐year surgical experience from a specialist hepato‐biliary unit. Annals of Surgery 1988;208:558‐64. - PMC - PubMed
Lise 1992 {published data only}
    1. Lise M, Feltrin G, Pian PP, Miotto D, Pilati PL, Rubaltelli L, et al. Giant cavernous hemangiomas: diagnosis and surgical strategies. World Journal of Surgery 1992;16:516‐20. - PubMed
Liu 2004 {published data only}
    1. Liu CL, Fan ST, Lo CM, Chan SC, Tso WK, Ng IO, et al. Hepatic resection for incidentaloma. Journal of Gastrointestinal Surgery 2004;8:785‐93. - PubMed
Nagorney 1995 {published data only}
    1. Nagorney DM. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World Journal of Surgery 1995;19(1):13‐8. - PubMed
Ozden 2000 {published data only}
    1. Ozden I, Emre A, Alper A, Tunaci M, Acarh K, Bilge O, et al. Long‐term results of surgery for liver hemangiomas. Archives of Surgery 2000;135:978‐81. - PubMed
Pain 1991 {published data only}
    1. Pain JA, Gimson AES, Williams R, Howard FR. Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut 1991;32:524‐7. - PMC - PubMed
Paineau 1994 {published data only}
    1. Paineau J, Hamy A, Visset J. Our surgical experience in the resection of benign hepatic tumors. Apropos of 31 cases [Notre experience surgicale d'exérèse des tumeurs hepatiques bénignes]. Journal de ChirurgieChirurgie 1994;131:461‐5. - PubMed
Popescu 2001 {published data only}
    1. Popescu I, Ciurea S, Brasoveau V, Hrhoret D, Boeti P, Georgescu S, et al. Liver hemangioma revisited: current surgical indications, techical aspects, results. Hepato‐gastroenterology 2001;48:770‐6. - PubMed
Reddy 2001 {published data only}
    1. Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E, Franceschi D, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors and outcome. Annals of Surgery 2001;67:173‐8. - PubMed
Schwartz 1987 {published data only}
    1. Schwartz SI, Husser WC. Cavernous hemangioma of the liver: a single institution report of 16 resections. Annals of Surgery 1987;205:456‐65. - PMC - PubMed
Terkivatan 2001 {published data only}
    1. Terkivatan T, Wilt JH, Man RA, Rijn RR, Zondervan PE, Tilanus HW, et al. Indications and long‐term outcome of treatment for benign hepatic tumors: a critical appraisal. Archives of Surgery 2001;136:1033‐8. - PubMed
Weiman 1997 {published data only}
    1. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, et al. Benign liver tumors: differential diagnosis and indication for surgery. World Journal of Surgery 1997;21:983‐90. - PubMed
Yamagata 1991 {published data only}
    1. Yamagata M, Kanematsu T, Matsumata T, Utsunomiya T, Ikeda Y, Sugimachi K. Management of haemangioma of the liver: comparison of results between surgery and observation. British Journal of Surgery 1991;78:1223‐5. - PubMed
Yoon 2003 {published data only}
    1. Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. Journal of American College of Surgery 2003;197:392‐402. - PubMed

Additional references

Belghiti 2000
    1. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty‐seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. Journal of the American College of Surgeons 2000;191:38‐46. - PubMed
Brancatelli 2001
    1. Brancatelli G, Federle MP, Grazioli L, Blanchar A, Pedersen MS, Thaete L. Focal nodular hyperplasia: CT findings with emphasis on muliphasic helical CT in 78 patients. Radiology 2001;219:61‐8. - PubMed
Charny 2001
    1. Charny CK, Jarnagin WR, Schwartz LH, Frommeyer HS, SeMatteo RP, Fong Y, et al. Management of 155 patients with benign liever tumours. British Journal of Surgery 2001;88:808‐13. - PubMed
De Wilt 1998
    1. Wilt JH, Man RA, Lameris JS, Zondervan PE, Tilanus HW, IJzermans JN. Hepatocellular adenoma in 20 patients; recommendations for treatment. Nederlands Tijdschrift voor Geneeskunde 1998;142:2459‐63. - PubMed
DeMets 1987
    1. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341‐50. [MEDLINE: ] - PubMed
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. [MEDLINE: ] - PubMed
Gandolfi 1991
    1. Gandolfi L, Leo P, Solmi L, Vitelli E, Verros G, Colecchia A. Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut 1991;32:677‐80. - PMC - PubMed
Gluud 2006
    1. Gluud C, Als‐Nielsen B, D'Amico G, Fingerhut A, Gluud LL, Khan S, et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2006, Issue 3. Art. No.: LIVER.
Gyorffy 1989
    1. Gyorffy EJ, Bredfeldt JE, Black WC. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Annals of Internal Medicine 1989;110:489‐90. - PubMed
Herman 2000
    1. Herman P, Pugliese V, Machado MA, Montagnini AL, Salem MZ, Bacchella T, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World Journal of Surgery 2000;24:372‐6. - PubMed
Higgins 2006
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & sons, Ltd.
Hung 2001
    1. Hung CH, Changchien CS, Lu SN, Eng HL, Wang JH, Lee CM, et al. Sonographic features of hepatic adenomas with pathologic correlation. Abdominal Imaging 2001;26:500‐6. - PubMed
Hussain 2004
    1. Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, Rave S, Ijzermans JN, et al. Focal nodular hyperplasia: findings at state‐of the art MR imaging, US, CT, and pathologic analysis. Radiographics 2004;24(1):3‐17. - PubMed
Ishak 2001
    1. Ishak KJ, Goodman ZD, Stocker JT. Tumors of the liver and intrahepatic bile ducts. Armed Forces Insitute of Pathology ‐ Bethesda, Maryland, USA. Washington DC, USA: Armed Forces Institute of Pathology, 2001 (Ed 3.) Fascicle No 31:10‐23.
Kjaergard 2001
    1. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9. [MEDLINE: ] - PubMed
Mathieu 2000
    1. Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000;118:560‐4. - PubMed
McCulloch 2002
    1. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions. BMJ (Clinical Research Ed.) 2002;324(7351):1448‐51. - PMC - PubMed
Moher 1998
    1. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13. [MEDLINE: ] - PubMed
Neuberger 1980
    1. Neuberger J, Porman B, Nunnerley HB, Laws JW, Davis M, Williams R. Oral‐contraceptive‐associated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancet 1980;1(8163):273‐6. - PubMed
Nguyen 1999
    1. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. American Journal of Surgical Pathology 1999;23:1441‐54. - PubMed
RevMan 2003 [Computer program]
    1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
Rooks 1979
    1. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, et al. Epidemiology of hepatocellular adenoma. JAMA 1979;242:644‐8. - PubMed
Royle 2003
    1. Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591‐603. - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12. [MEDLINE: ] - PubMed
Terkivatan 2001
    1. Terkivatan T, Wilt JH, Man RA, Rijin RR, Zondervan PE, Tilanus HW, et al. Indications and long term outcome of treatment for benign hepatic tumors: a critical appraisal. Archives of Surgery 2001;136:1033‐8. - PubMed
Trotter 2001
    1. Trotter JF, Everson GT. Benign focal lesions of the liver. Clinical Liver Diseases 2001;5:17‐42. - PubMed
Weimann 1997
    1. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, et al. Benign liver tumors: differential diagnosis and indications for surgery. World Journal of Surgery 1997;21:883‐90. - PubMed

Publication types

MeSH terms